Company / Book Value per Share
Tvardi Therapeutics, Inc. Book Value per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$12.574
FY2024
5-year range
$2.86 / $12.574
FY2020-FY2024
Trend
+197.3%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Book Value per Share has fluctuated over the past 10 years, ranging from -$2.371 in FY2015 to $12.574 in FY2024.
Based on SEC 10-K filings.
$12.574 in FY2024 with a 5-year CAGR of +41.8%.
Improved from $4.656 to $12.574 over the past 2 years.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +49.8%
- 5-Year CAGR
- +41.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +41.8%, indicating consistent growth.
- In FY2024, book value per share increased 197.3% year-over-year.
- Lowest book value per share in the period was in FY2015.
Company context
Key Data Points
- Altman Z-Score -6.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $12.574 | +197.3% |
| FY2023 | $4.229 | -9.2% |
| FY2022 | $4.656 | +24.4% |
| FY2021 | $3.744 | +30.9% |
| FY2020 | $2.86 | +30.3% |
| FY2019 | $2.194 | +41.3% |
| FY2018 | $1.553 | -59.6% |
| FY2017 | $3.848 | +103.0% |
| FY2016 | $1.896 | +179.9% |
| FY2015 | -$2.371 | +82.5% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026